During the last session, ATAI Life Sciences N.V (NASDAQ:ATAI)’s traded shares were 1.39 million, with the beta value of the company hitting 1.22. At the end of the trading day, the stock’s price was $1.40, reflecting an intraday gain of 0.72% or $0.01. The 52-week high for the ATAI share is $2.57, that puts it down -83.57 from that peak though still a striking 26.43% gain since the share price plummeted to a 52-week low of $1.03. The company’s market capitalization is $279.72M, and the average trade volume was 2.36 million shares over the past three months.
ATAI Life Sciences N.V (ATAI) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.00. ATAI has a Sell rating from 0 analyst(s) out of 1 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 1 recommend a Buy rating for it.
ATAI Life Sciences N.V (NASDAQ:ATAI) trade information
ATAI Life Sciences N.V (ATAI) registered a 0.72% upside in the last session and has traded in the red over the past 5 sessions. The stock spiked 0.72% in intraday trading to $1.40, hitting a weekly high. The stock’s 5-day price performance is -4.76%, and it has moved by 15.70% in 30 days. Based on these gigs, the overall price performance for the year is -33.96%.
The consensus price target of analysts on Wall Street is $6, which implies an increase of 76.67% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $6 and $6 respectively. As a result, ATAI is trading at a discount of -328.57% off the target high and -328.57% off the low.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 18.62%. While earnings are projected to return 23.00% in 2025, the next five years will return 17.72% per annum.
ATAI Dividends
ATAI Life Sciences N.V is due to release its next quarterly earnings in June. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
The next largest institutional holding, with 2.72 million shares, is of MORGAN STANLEY’s that is approximately 1.6952% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $3.62 million.
Also, the Mutual Funds coming in first place with the largest holdings of ATAI Life Sciences N.V (ATAI) shares are MORGAN STANLEY INSTITUTIONAL FUND INC-Inception Portfolio and AdvisorShares Trust-AdvisorShares Psychedelics ETF . Data provided on Dec 31, 2024 indicates that MORGAN STANLEY INSTITUTIONAL FUND INC-Inception Portfolio owns about 511.99 shares. This amounts to just over 0.26 percent of the company’s overall shares, with a $0.72 million market value. The same data shows that the other fund manager holds slightly less at 408.76, or about 0.20% of the stock, which is worth about $0.57 million.
